Barinthus Biotherapeutics Plc ADR
(BRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -22,698 | N/A | N/A |
| Depreciation Amortization | 345 | N/A | N/A |
| Accounts receivable | -959 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,965 | N/A | N/A |
| Other Working Capital | 3,068 | N/A | N/A |
| Other Operating Activity | -1,404 | 0 | 0 |
| Operating Cash Flow | $-18,682 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -124 | N/A | N/A |
| Investing Cash Flow | $-124 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 2,045 | 0 | 0 |
| Financing Cash Flow | $2,045 | $N/A | $N/A |
| Exchange Rate Effect | -444 | N/A | N/A |
| Beginning Cash Position | 28,638 | N/A | N/A |
| End Cash Position | 11,432 | N/A | N/A |
| Net Cash Flow | $-17,206 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -18,682 | N/A | N/A |
| Capital Expenditure | -128 | N/A | N/A |
| Free Cash Flow | -18,810 | 0 | 0 |